973 related articles for article (PubMed ID: 20001742)
21. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G
Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206
[TBL] [Abstract][Full Text] [Related]
23. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
24. Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia.
Stepanshina VN; Panfertsev EA; Korobova OV; Shemyakin IG; Stepanshin YG; Medvedeva IM; Dorozhkova IR
Int J Tuberc Lung Dis; 1999 Feb; 3(2):149-52. PubMed ID: 10091881
[TBL] [Abstract][Full Text] [Related]
25. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
26. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
27. Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Li G; Zhang J; Guo Q; Jiang Y; Wei J; Zhao LL; Zhao X; Lu J; Wan K
PLoS One; 2015; 10(2):e0119013. PubMed ID: 25695504
[TBL] [Abstract][Full Text] [Related]
28. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
29. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
30. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Bercion R; Kuaban C
Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
[TBL] [Abstract][Full Text] [Related]
31. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.
Kardan-Yamchi J; Kazemian H; Haeili M; Harati AA; Amini S; Feizabadi MM
J Glob Antimicrob Resist; 2019 Jun; 17():201-208. PubMed ID: 30654147
[TBL] [Abstract][Full Text] [Related]
32. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Laszlo A; Rahman M; Raviglione M; Bustreo F
Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
[TBL] [Abstract][Full Text] [Related]
33. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
35. [Characterization of the drug resistance spectrum of rifampicin-resistant M. tuberculosis to other first-line antituberculous drugs].
Isakova ZhT; Goncharova ZK; Aldashev AA
Probl Tuberk Bolezn Legk; 2008; (11):39-42. PubMed ID: 19140379
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Ani AE; Idoko J; Dalyop YB; Pitmang SL
Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
[TBL] [Abstract][Full Text] [Related]
37. Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates.
Li G; Zhang J; Guo Q; Wei J; Jiang Y; Zhao X; Zhao LL; Liu Z; Lu J; Wan K
J Antibiot (Tokyo); 2015 Jul; 68(7):431-5. PubMed ID: 25690361
[TBL] [Abstract][Full Text] [Related]
38. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
39. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.
Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C
Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805
[TBL] [Abstract][Full Text] [Related]
40. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
